» Articles » PMID: 8991940

Immunoblot Detection of Antibodies to Toscana Virus

Overview
Journal J Med Virol
Specialty Microbiology
Date 1996 Jun 1
PMID 8991940
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Sera from patients with sandfly fever caused by Toscana virus (TOSV) infection were tested by immunoblot for specific antibody response to TOSV derived from infected Vero-E6 cells. The 28 kDa TOSV nucleoprotein (N) was identified as the major immunodominant protein recognized by immunoblot. In sera of patients with acute TOSV infection, specific antibodies of the IgM, IgA, and IgG class were detected. Using sandfly fever virus, serotypes Sicilian (SFSV) and Naples (SFNV), as antigens for immunoblot, TOSV antibody-positive sera cross-reacted with the corresponding N proteins. These sera reacted for IgM and IgG by SFSV immunoblot, and for IgM by SFNV immunoblot. The diagnosis of sandfly fever may be confirmed by TOSV immunoblot.

Citing Articles

Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis.

Huang J, Adungo F, Konongoi S, Inoue S, Zhan L, Sang R Pathogens. 2024; 13(7).

PMID: 39057809 PMC: 11279541. DOI: 10.3390/pathogens13070582.


Reagents for detection of Rift Valley fever virus infection in sheep.

Shiell B, Ye S, Harper J, van der Heide B, Beddome G, Foord A J Vet Diagn Invest. 2020; 32(4):577-580.

PMID: 32450762 PMC: 7438644. DOI: 10.1177/1040638720926476.


Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.

Yu F, Adungo F, Konongoi S, Inoue S, Sang R, Ashur S Virol J. 2018; 15(1):178.

PMID: 30466469 PMC: 6249750. DOI: 10.1186/s12985-018-1071-y.


Heartland Virus Epidemiology, Vector Association, and Disease Potential.

Brault A, Savage H, Duggal N, Eisen R, Staples J Viruses. 2018; 10(9).

PMID: 30223439 PMC: 6164824. DOI: 10.3390/v10090498.


Development of vaccines against Crimean-Congo haemorrhagic fever virus.

Dowall S, Carroll M, Hewson R Vaccine. 2017; 35(44):6015-6023.

PMID: 28687403 PMC: 5637709. DOI: 10.1016/j.vaccine.2017.05.031.